Oncternal Therapeutics Inc (ONCT) — Capital Reinvestment Ratio

Latest as of March 2008: 0.02x

Oncternal Therapeutics Inc (ONCT) has a Capital Reinvestment Ratio of 0.02x as of March 2008, meaning it reinvests 0% of its operating cash flow ($28.70 Million) in capital expenditures ($697.00K). See ONCT equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$28.70 Million

USD

Capital Expenditures

$697.00K

USD

Data as of

Mar 2008

Most recent filing

Annual Capital Reinvestment Ratio for Oncternal Therapeutics Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Oncternal Therapeutics Inc from None to None. For live market cap and broader valuation context, see Oncternal Therapeutics Inc (ONCT) total market value.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow